flash news

Based on early data from the first-ever clinical trial in humans in the US, genetically editing a cancer patient’s immune cells using CRISPR/Cas9 technology and infusing them back into the patient seems to be safe and feasible. Three participants in the trial (two with multiple myeloma and one with sarcoma) …

In ongoing lawsuits in the USA, claims have been made that Zantac and ranitidine contain unacceptable levels of the cancer-causing chemical N-Nitrosodimethylamine, or NDMA. Lawyers have charged that NDMA contamination causes stomach, liver, and bladder cancer. In September 2019, an online pharmacy had alerted the U.S. Food and Drug Administration …

Once upon a time, getting a blood transfusion was a highly a risky affair, because some people receiving donated blood were apt to get chronic hepatitis (liver inflammation) from an unknown, mysterious disease. And, although the Hepatitis A and Hepatitis B viruses were discovered by the mid-1960s, in 1972, Prof. …

Pfizer and BioNTech’s COVID-19 vaccine has been authorized for emergency use in the United Kingdom, which has ordered 40 million doses, enough for 20 million people, since two doses are required for each individual. The government expects to receive 10 million doses before the end of the year. The developers …

Siberia’s Vector Research Center has claimed that all volunteers vaccinated by its COVID-19 vaccine, EpiVacCorona, developed antibodies, although the first two phases of testing involved only 100 volunteers. The center reported, “Clinical studies have shown that antibodies were detected in 100% of the volunteers immunized with the EpiVacCorona vaccine, Most …

  The development of the COVID-19 vaccine is a worldwide effort involving some of the best biological and pharmaceutical companies. Not only is it an effort involving massive amounts of money, but also, a race among nations for prestige and achievement. As of date, the leading companies with their COVID-19 …

Results of a World Health Organization coordinated study show that remdesivir has “little or no effect on mortality” for patients hospitalized with coronavirus, and that it doesn’t seem to help patients recover any faster. Till date, this antiviral drug was the only drug that the US FDA had granted COVID-19 …

After government approval of Sputnik V, Russia’s first COVID-19 vaccine, on August 11, 2020, health authorities have, on October 14, 2020, approved its second vaccine, EpiVacCorona, developed by Novosibirsk’s Vektor [State Virology and Biotechnology Center], as it starts large-scale trials. According to President Putin, his deputy prime minister and the …

In May 2020, the US Environmental Agency approved production of the genetically engineered, male Aedes aegypti mosquitoes, known as OX5034, by British-based, US-operated company Oxitec. This species of mosquitoes are known to spread deadly diseases like dengue, Zika, chikungunya, and yellow fever. On August 18, 2020, Florida Keys Mosquito Control …

On June 11, 2020, Regeneron Pharmaceuticals initiated the first of its randomized, placebo-controlled clinical trials of REGN-COV2, its experimental dual antibody cocktail for the prevention and treatment of COVID-19. Th e trials were conducted at multiple sites and consisted of four study populations—hospitalized COVID-19 patients, non- hospitalized symptomatic COVID-19 patients, …